Biodetection Technologies is an internationally recognized event for experts in detection and identification of biological and chemical threats.
Boston, MA (PRWEB) June 06, 2011
The Knowledge Foundation’s 18th Biodetection Technologies conference will be held from June 23-24, 2011 at the Marriott Wardman Park in Washington, DC. Biodetection Technologies is an internationally recognized event for experts in detection and identification of biological and chemical threats and will explore the latest R&D developments as well as ready-to-market systems for biothreat detection, identification, and analysis both in the field and at the point-of-care. The keynote address, to be delivered by Dr. Peter Emanuel, BioScience Division Chief at the U.S. Army Edgewood Chemical Biological Center, will reveal the results from the 2011 Department of Defense commissioned survey on technologies for detection of chemical, biological and radiological threats.
About the Survey
The Joint Program Executive Office for Chemical and Biological Defense and the Defense Threat Reduction Agency/Joint Science and Technology Office tasked the U.S. Army Edgewood Chemical Biological Center and Johns Hopkins Applied Physics Laboratory to compile a technology survey on biosurveillance hardware systems which have applicability in assessing human exposure to chemical, biological, and radiological agents. This survey targeted information on commercially available and maturing diagnostic and identification/detection products that have technology readiness levels from TRL 4 to TRL 9 which does not include basic research concepts. Dr. Emanuel will discuss what this effort found and what it may mean for the interagency needs for purchasing technologies in the coming years.
Other topics to be explored when international experts convene for this high-level symposium include:
- Technological advances in detection & identification of biological threats
- Point-of-care applications for pathogen, virus & threat detection & identification
- Challenges for rapid, early, specific & sensitive detection
- Role of nanotechnology and system miniaturization - MEMS & bioMEMS
- Use of biochip technology - micro- & nanofluidics
- Bioinformatics for biodefense
- Field-deployable devices: portability/compatibility/reliability/scalability
- Reagentless vs. reagent biodetection systems
- Non-PCR vs. PCR-based detection techniques
- David Almassian, Tetracore, Inc.
- Amy L. Altman, PhD, Luminex Corporation
- Christopher Anton, PhD, Episensors, Inc.
- Marie Binet, EDF
- Amos Danielli, PhD, Washington University in St. Louis
- Peter Emanuel, PhD, US Army Edgewood Chemical Biological Center
- Matthias Frank, PhD, Lawrence Livermore National Laboratory
- Julie Fruetel, PhD, Sandia National Laboratories
- Andrei Gindilis, PhD, SHARP Laboratories of America
- Robert Haushalter, PhD, Parallel Synthesis Technologies
- Ryan Kim, PhD, National Center for Genome Resources
- Steve Jackinsky, MS, Wi, Inc.
- Kiyoshi Nokihara, DPharmSci, HiPep Laboratories
- Natasha Paul, PhD, TriLink BioTechnologies, Inc.
- Ze'ev Russak, Azure PCR Limited
- Shanmuga Sozhamannan, PhD, Naval Medical Research Center
- Robert F. Standaert, PhD, Oak Ridge National Laboratory
- Yi-Wei Tang, MD, PhD, Vanderbilt University Medical Center
- Willy A. Valdivia-Granda, PhD, Orion Integrated Biosciences Inc.
- Francisco Veas, PhD, University Montpellier 1
- Felix von Stetten, PhD, University of Freiburg
- Reinhold Wimberger-Friedl, PhD, Philips Research
About The Knowledge Foundation
The Knowledge Foundation integrates scientific ingenuity and real-world applications by fostering collaborative research at the rapidly changing intersection of science and business. Known for providing members of its Technology Commercialization Alliance with direct and unbiased state-of-the-art scientific information, the Knowledge Foundation is uniquely qualified to provide wider exposure for important developments in the emerging fields of alternative energy, nanotechnology, and chemical/biological detection technologies.